BTG2 and central nervous system cancer: Furthermore, in glioma, <i>PC3</i>/<i>Tis21</i>/<i>BTG2</i> enhances apoptosis rates while simultaneously decreasing the migration and invasion of cancerous cells, and lowering the levels of <i>cyclin D1</i>.